Johnson Matthey PLC (LON:JMAT – Get Free Report) insider Liam Condon bought 24 shares of the company’s stock in a transaction dated Wednesday, April 17th. The shares were acquired at an average price of GBX 1,767 ($22.00) per share, for a total transaction of £424.08 ($527.92).
Johnson Matthey Price Performance
Shares of LON:JMAT opened at GBX 1,788 ($22.26) on Friday. Johnson Matthey PLC has a fifty-two week low of GBX 1,428.50 ($17.78) and a fifty-two week high of GBX 1,984 ($24.70). The business has a 50-day simple moving average of GBX 1,706.43 and a two-hundred day simple moving average of GBX 1,627.20. The company has a debt-to-equity ratio of 63.95, a quick ratio of 0.76 and a current ratio of 1.51. The firm has a market cap of £3.28 billion, a price-to-earnings ratio of 1,862.50, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.98.
Analysts Set New Price Targets
Several equities analysts have recently issued reports on the company. Berenberg Bank lifted their price target on Johnson Matthey from GBX 1,650 ($20.54) to GBX 1,800 ($22.41) and gave the stock a “hold” rating in a research report on Monday, April 8th. Numis Securities reaffirmed a “buy” rating and issued a GBX 2,200 ($27.39) price target on shares of Johnson Matthey in a research report on Wednesday, March 20th. Finally, Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 2,100 ($26.14) price target on shares of Johnson Matthey in a research report on Wednesday, March 20th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of GBX 2,010 ($25.02).
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Featured Articles
- Five stocks we like better than Johnson Matthey
- What Are Dividend Champions? How to Invest in the Champions
- Comprehensive Analysis of PayPal Stock
- How to Invest in Small Cap Stocks
- Intuitive Surgical Stock Can Trend Much Higher This Year
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.